PHR / Phreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions more_horizontal

While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended July 2023, it could be worth more_horizontal

Phreesia, Inc. (NYSE:PHR ) Q2 2024 Earnings Conference Call September 6, 2023 5:00 PM ET Company Participants Chaim Indig - Chief Executive Officer Ba more_horizontal

Phreesia (PHR) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.8 more_horizontal

Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

The consensus price target hints at a 27.3% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardl more_horizontal

Phreesia, Inc. provides a suite of patient care software and services to healthcare providers in the U.S. and Canada. Management recently guided to sl more_horizontal

I reiterate a buy rating for PHR due to its strong execution and consistent addition of new logos, despite the uncertain environment. PHR's conservati more_horizontal